Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Exchange Rate Effect (2017 - 2022)

Historic Exchange Rate Effect for Nephros (NEPH) over the last 13 years, with Q1 2022 value amounting to -$2000.0.

  • Nephros' Exchange Rate Effect rose 6000.0% to -$2000.0 in Q1 2022 from the same period last year, while for Dec 2022 it was -$2000.0, marking a year-over-year increase of 8181.82%. This contributed to the annual value of -$2000.0 for FY2022, which is 8181.82% up from last year.
  • Latest data reveals that Nephros reported Exchange Rate Effect of -$2000.0 as of Q1 2022, which was up 6000.0% from -$5000.0 recorded in Q4 2021.
  • In the past 5 years, Nephros' Exchange Rate Effect ranged from a high of $5000.0 in Q4 2020 and a low of -$8000.0 during Q2 2018
  • Moreover, its 5-year median value for Exchange Rate Effect was -$2000.0 (2019), whereas its average is -$1692.3.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first tumbled by 30000.0% in 2019, then skyrocketed by 15000.0% in 2020.
  • Quarter analysis of 5 years shows Nephros' Exchange Rate Effect stood at -$8000.0 in 2018, then skyrocketed by 125.0% to $2000.0 in 2019, then surged by 150.0% to $5000.0 in 2020, then crashed by 200.0% to -$5000.0 in 2021, then surged by 60.0% to -$2000.0 in 2022.
  • Its last three reported values are -$2000.0 in Q1 2022, -$5000.0 for Q4 2021, and -$2000.0 during Q3 2021.